Kura Oncology Inc’s recently made public that its SVP, Finance & Accounting DOYLE THOMAS JAMES unloaded Company’s shares for reported $38958.0 on Jan 28 ’25. In the deal valued at $7.87 per share,4,949 shares were sold. As a result of this transaction, DOYLE THOMAS JAMES now holds 88,193 shares worth roughly $0.69 million.
Then, Leoni Mollie sold 4,963 shares, generating $39,068 in total proceeds. Upon selling the shares at $7.87, the Chief Medical Officer now owns 88,253 shares.
Before that, Bair Teresa Brophy sold 7,281 shares. Kura Oncology Inc shares valued at $57,315 were divested by the Chief Legal Officer at a price of $7.87 per share. As a result of the transaction, Bair Teresa Brophy now holds 107,948 shares, worth roughly $0.84 million.
UBS initiated its Kura Oncology Inc [KURA] rating to a Buy in a research note published on October 24, 2024; the price target was $27. A number of analysts have revised their coverage, including Stifel’s analysts, who decreased its forecast for the stock in mid October from “a Buy” to “a Hold”. Mizuho began covering KURA with “Buy” recommendation on December 22, 2023. BofA Securities started covering the stock on August 11, 2023. It rated KURA as “a Buy”.
Price Performance Review of KURA
On Tuesday, Kura Oncology Inc [NASDAQ:KURA] saw its stock fall -1.77% to $7.77. Over the last five days, the stock has gained 5.14%. Kura Oncology Inc shares have fallen nearly -10.79% since the year began. Nevertheless, the stocks have fallen -58.52% over the past one year. While a 52-week high of $24.17 was reached on 01/06/25, a 52-week low of $6.98 was recorded on 01/13/25. SMA at 50 days reached $10.00, while 200 days put it at $17.40.
Levels Of Support And Resistance For KURA Stock
The 24-hour chart illustrates a support level at 7.61, which if violated will result in even more drops to 7.46. On the upside, there is a resistance level at 7.91. A further resistance level may holdings at 8.06. The Relative Strength Index (RSI) on the 14-day chart is 36.01, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.27, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 53.42%. Stochastics %K at 49.39% indicates the stock is a holding.
How much short interest is there in Kura Oncology Inc?
A steep rise in short interest was recorded in Kura Oncology Inc stocks on 2025-01-15, dropping by -0.75 million shares to a total of 8.14 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 8.89 million shares. There was a decline of -9.2%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on July 27, 2023 when Scotiabank began covering the stock and recommended ‘”a Sector perform”‘ rating along with a $10.50 price target.
